Abdel AssizF. (2000). Hepatitis C virus (HCV) infection in a community in Lower Egypt: Population, description and HCV prevalence. Hepatology, 32, 111–115.
2.
Abdel-WahabM. F. (1994). High seroprevalence of hepatitis C infection among risk groups in Egypt. American Journal of Tropical Medicine and Hygiene, 54, 563–7.
3.
DarwishM. A.FarisR.ClemensR. J. D.RaoM.R., & EdelmanR. (1995). High seroprevalence of hepatitis A, B, C, and E Viruses in residents in an Egyptian village in the Nile delta: a pilot study. American Journal of Tropical Medicine and Hygiene, 1995, 54, 554–558.
4.
Editorial (1998). Combination therapy for hepatitis C infection. New England Journal of Medicine, 339, 1549–50.
5.
GilliesP. (1998). Effectiveness of alliances and partnerships for health promotion. Health Promotion International, 13, 99–120.
6.
GraeffJ. A.ElderJ. P., & BoothE. M. (1993). Communication for health and behavior change: a developing country perspective.San Francisco: Jossey-Bass Publishers.
7.
HabibM. (2001) Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology33, 248–253.
8.
Institute of National Planning. (1998). Egypt Human Development Report 1997/98, Cairo, 51–52.
9.
KamalM. A.GhaffarY. A.WasefM. A.WrightM.ClarkL. C., & MillerF. D. (1992). High HCV prevalence in Egyptian blood donors. Lancet, II (340), 427.
10.
KleinR. C.PartyE., & GersheyE. L. (1990). Virus penetration of examination gloves. Biotechniques, 9, 196–9.
11.
MastE. E.AlterM. J., & MargolisS. H. (1999). Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine, 17, 1730–3.
12.
McHutchisonJ. G. (1998) Interferon Alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. New England Journal of Medicine, 339. 1485–1493.
13.
NafehM.A. (2001) Hepatitis C virus infection in a community in Upper Egypt: 1. Cross sectional survey. American Journal of Tropical Medicine and Hygiene, 63, 236–41.
14.
OsmanM. O., & JensenS. L.Surgical gloves: current problems. World Journal of Surgery, 23, 630–7.
15.
SimonsenL.KaneA.LloydJ.ZaffranM., & KaneM. (1999) Review: unsafe injections in the developing world and the transmission of blood-borne pathogens. Bulletin of the World Health Organization77, 789–800.
16.
StoszekS. (2000) Vertical transmission of hepatitis C virus (HCV) in a Nile delta community: preliminary results. Conference on New Challenges in Tropical Medicine and Parasitology, 18–22 September 2000, Oxford: UK.
17.
WaledI. A.SalehS. M.MoustafaM. S.RaoufA. A.ThomasD. L., & StricklandG. T. (1995) High prevalence of hepatitis C in Egyptian patients with chronic liver disease. Gut36, 111–113.
18.
YatesS. C. (1999) Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with (HCV) RNA level. American Journal of Tropical Medicine and Hygiene60, 714–20.